Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-11Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis VolatilomeChemBioChem · 2026-03-31Pilot study of psilocybin in patients with post-treatment lyme diseaseScientific Reports · 2026-02-24SSRIs, Psilocybin, MDMA, and Disease Modeling: Strategies to Advance PTSD TreatmentUnknown journal · 2026-02-23Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanismsNeuropharmacology · 2026-01-20Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trialGeneral Hospital Psychiatry · 2025-08-11Rise of the Mushrooms: Effects of Psilocybin Reforms on Psychedelic Usage PatternsJournal of Public Policy & Marketing · 2025-07-15Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe MetabolomeChemBioChem · 2025-05-02In Vitro Psilocybin Synthesis by Co-Immobilized EnzymesChemistry - A European Journal · 2025-04-08Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case reportPsychiatry Research · 2025-01-28Psychedelic Medicine Exceptionalism.The American journal of bioethics: AJOB · 2024-12-31Selective Serotonin Reuptake Inhibitor Discontinuation for Psilocybin Treatment and Contributions to Alcohol Addiction RelapseThe Journal of Clinical Psychiatry · 2024-08-24Identifying Three Psilocybin Use Patterns by Frequency and QuantityJournal of Studies on Alcohol and Drugs · 2024-08-22Psilocybin for clinical indications: A scoping review.Unknown journal · 2024-08-12Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depressionTrials · 2024-07-02Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13Cannabis and Psilocybin: Insurance Reimbursement, Legalization, and ReschedulingHealth Law Outlook · 2023-12-31Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorderCancer · 2023-12-17Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?Research Directions Depression · 2023-10-12Psilocybin Use in Palliative Care #464Journal of Palliative Medicine · 2023-08-31Therapeutic potential of psilocybin: a promising agent in treating major depressive disorderAIDASCO Reviews · 2023-01-16The varieties of psychedelic law.Unknown journal · 2022-12-20Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test?Journal of Humanistic Psychology · 2022-08-17Genetic Survey of Psilocybe Natural Products.ChemBioChem · 2022-06-08The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.Unknown journal · 2022-04-25Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.Unknown journal · 2022-01-26Exploratory review of psilocybin usage and awareness amongst college students and potential consumer goods tradeoffs resulting from increased usageInternational Journal of Research in Marketing Management and Sales · 2021-12-31Mit Psilocybin gegen DepressionInFo Neurologie + Psychiatrie · 2021-07-31Effects of the putative antidepressant psilocin on the lipid-raft proteome and lipid-raft signalingThe FASEB Journal · 2021-04-30Psychedelics and Psychedelic-Assisted Psychotherapy.Focus (American Psychiatric Publishing) · 2020-12-31Psychedelics and Psychedelic-Assisted Psychotherapy.Diseño interior · 2020-02-25S-Adenosyl-l-Methionine Salvage Impacts Psilocybin Formation in “Magic” MushroomsChemBioChem · 2019-12-03Injury-Triggered Blueing Reactions of Psilocybe “Magic” MushroomsAngewandte Chemie · 2019-11-13Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psychopharmacology · 2017-11-07Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Scientific Reports · 2017-10-12Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.The Lancet Psychiatry · 2016-05-16Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.Molecular & Cellular Proteomics · 2014-03-16Broadband cortical desynchronization underlies the human psychedelic state.Journal of Neuroscience · 2013-08-31Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.Neuropsychopharmacology · 2011-09-27Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.Journal of Psychopharmacology · 2010-12-07Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.Journal of Psychopharmacology · 2007-04-30The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.Neuropsychopharmacology · 2007-02-13